NF-κB inhibition delays DNA damage–induced senescence and aging in mice
Open accessThe DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
The accumulation of cellular damage, including DNA damage, is thought to contribute to aging-related degenerative changes, but how damage drives aging is unknown. XFE progeroid syndrome is a disease of accelerated aging caused by a defect in DNA repair. NF-κB, a transcription factor activated by cellular damage and stress, has increased activity with aging and aging-related chronic diseases. To determine whether NF-κB drives aging in response to the accumulation of spontaneous, endogenous DNA damage, we measured the activation of NF-κB in WT and progeroid model mice. As both WT and progeroid mice aged, NF-κB was activated stochastically in a variety of cell types. Genetic depletion of one allele of the p65 subunit of NF-κB or treatment with a pharmacological inhibitor of the NF-κB-activating kinase, IKK, delayed the age-related symptoms and pathologies of progeroid mice. Additionally, inhibition of NF-κB reduced oxidative DNA damage and stress and delayed cellular senescence. These results indicate that the mechanism by which DNA damage drives aging is due in part to NF-κB activation. IKK/NF-κB inhibitors are sufficient to attenuate this damage and could provide clinical benefit for degenerative changes associated with accelerated aging disorders and normal aging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SASP inhibitors (senomorphics) can directly or indirectly attenuate the SASP of senescent cells by inhibiting transcription factor nuclear factor (NF)-κB, the JAK-STAT signal transduction pathway, the serine/threonine protein kinase mTOR, mitochondrial complex-1-related or 4-related targets, or other pathways involved in the induction and maintenance of the SASP103–106.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [104]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In vitro and in vivo, inhibitors of NF-κB (mediating the cell response to inflammation), can reduce pro-inflammatory SASP cytokines and chemokines104.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [104]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, removal of senescent cells promotes healthy aging in mice, making senescence‐associated inflammatory signaling an attractive target of therapeutic intervention for aging and age‐related disease (Tilstra et al, 2012; Childs et al, 2015; Baker et al, 2016; Ogrodnik et al, 2021).”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Tilstra et al, 2012
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“genetic and pharmacological inhibition of NF-κB signaling prevents age-associated features in different mouse models of accelerated aging”
From The Hallmarks of Aging (2013) · cites this paper as Tilstra et al., 2012
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Transcription factor enrichment analysis in Sen cells in all conditions revealed enrichment occupancy of key regulators of inflammation and the SASP, including NF-κB32, C/EBPβ33 and STAT1/3 (ref. 34), and of matrix remodelling/fibrosis, including SMAD3/4 (and inhibition of SMAD7)35 (Fig. 4c).”
From Senescence atlas reveals an aged-like inflamed niche that blunts muscle regeneration (2023) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A simple salting out procedure for extracting DNA from human nucleated cells
Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.3.1215 · Cited by 20,330 · cited 1×
“lated from mouse livers using a high-salt method (88) and analyzed for”
MethodShared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,494
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290 · cited 1×
“In contrast to the results with rapamycin and our results with NBD, treatment with resveratrol and other SIRT agonists appears only able to extend healthspan and life span in mice on high-fat diets (76).”
ResultRapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766 · cited 1×
“The magnitude of the effect on healthspan elicited by NF-κB inhibition has only been observed in outbred mice treated with rapamycin (73), which targets the mTOR pathway, or by genetic deletion of S6K1, a downstream target of mTOR (74).”
BackgroundClearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Premature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
Farrell, G. C., & Larter, C. Z. (2006) · Hepatology · doi:10.1002/hep.20973 · Cited by 2,414
Rejuvenation of aged progenitor cells by exposure to a young systemic environment
Conboy, I. M., Conboy, M. J., Wagers, A. J., Girma, E. R., Weissman, I. L., & Rando, T. A. (2005) · Nature · doi:10.1038/nature03260 · Cited by 2,287
The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D’Amico, M., Pestell, R., & Ben-Ze’ev, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5522 · Cited by 2,230
Research works printed but not linked: 3
- Tilstra, 2011, Aging Dis., 2, 449
- 10.1073/pnas.0704908104 · DOI · Paper page
- Tappel, 1973, Fed Proc., 32, 1870
Cited by
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
“Likewise, genetic and pharmacological inhibition of NF-kB signaling prevents age-associated features in different mouse models of accelerated aging (Osorio et al., 2012; Tilstra et al., 2012).”
BackgroundThe Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584
Self-citationThe cGAS–cGAMP–STING pathway connects DNA damage to inflammation, senescence, and cancer
Li, T., & Chen, Z. J. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180139 · Cited by 1,293
“While the aging phenotype of ERCC1 deficiency requires NF-κB in mice (Tilstra et al., 2012), it remains to be determined whether aberrant cGAS–STI NG activity may also underpin these inheritable disorders.”
BackgroundSenescence and aging: Causes, consequences, and therapeutic avenues
McHugh, D., & Gil, J. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201708092 · Cited by 1,233
“IL-1α, IL-6, TNF, and NF-κB activity and other inflammatory factors have been found to increase in tissues with age and inhibition of NF-κB confers resistance to progeroid conditions (Tilstra et al., 2012).”
BackgroundCellular senescence and senolytics: the path to the clinic
Chaib, S., Tchkonia, T., & Kirkland, J. L. (2022) · Nature Medicine · doi:10.1038/s41591-022-01923-y · Cited by 1,134
NF-kappaB Signaling Pathways in Neurological Inflammation: A Mini Review
Shih, R.-H., Wang, C.-Y., & Yang, C.-M. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00077 · Cited by 910
“Notably, RelA is demonstrated as a most contributing subunit in degenerative changes associated with senescence in a mice model (Tilstra et al., 2012).”
BackgroundExploiting senescence for the treatment of cancer
Wang, L., Lankhorst, L., & Bernards, R. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00450-9 · Cited by 867
Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
Moss, B. J., Ryter, S. W., & Rosas, I. O. (2022) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-042320-030240 · Cited by 821
Chronic inflammation induces telomere dysfunction and accelerates ageing in mice
Jurk, D., Wilson, C., Passos, J. F., Oakley, F., Correia-Melo, C., Greaves, L., Saretzki, G., Fox, C., Lawless, C., Anderson, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms5172 · Cited by 819
Mechanisms and therapeutic implications of cellular senescence in osteoarthritis
Coryell, P. R., Diekman, B. O., & Loeser, R. F. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00533-7 · Cited by 761
Targeting cellular senescence with senotherapeutics: senolytics and senomorphics
Zhang, L., Pitcher, L. E., Prahalad, V., Niedernhofer, L. J., & Robbins, P. D. (2023) · The FEBS Journal · doi:10.1111/febs.16350 · Cited by 621
Self-citationMoiseeva, O., Deschênes‐Simard, X., St‐Germain, E., Igelmann, S., Huot, G., Cadar, A. E., Bourdeau, V., Pollak, M. N., & Ferbeyre, G. (2013) · Aging Cell · doi:10.1111/acel.12075 · Cited by 654
“…of microarray data from several aged tissues indicated that NF-jB was the transcription factor most associated to changes in gene expression during aging (Adler et al., 2007) and reducing NF-jB activity attenuated the accelerated aging phenotype of a mouse model of progeria (Tilstra et al., 2012).”
BackgroundSivandzade, F., Prasad, S., Bhalerao, A., & Cucullo, L. (2019) · Redox Biology · doi:10.1016/j.redox.2018.11.017 · Cited by 639
Cellular senescence: a key therapeutic target in aging and diseases
Zhang, L., Pitcher, L. E., Yousefzadeh, M. J., Niedernhofer, L. J., Robbins, P. D., & Zhu, Y. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158450 · Cited by 631
“Abolishing NF-κB–dependent SASP delayed the onset of progeroid symptoms and extended healthspan in Ercc1–/Δ mice (75).”
BackgroundSelf-citationGenetic and biological hallmarks of colorectal cancer
Li, J., Ma, X., Chakravarti, D., Shalapour, S., & DePinho, R. A. (2021) · Genes & Development · doi:10.1101/gad.348226.120 · Cited by 573
“Furthermore, TANs and TAMs are known to inhibit CTL activity via high production of ARG1 and ROS (Doedens et al. 2010; Movahedi et al. 2010; Wu et al. 2014) and promote CRC metastasis, given that inhibition of PMN MDSCs by blocking the key receptor CXCR2 leads to a reduction inmetastatic disease (Jackstadt et al. 2019…”
BackgroundInfluentialCellular and molecular biology of aging endothelial cells
Donato, A. J., Morgan, R. G., Walker, A. E., & Lesniewski, L. A. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.01.021 · Cited by 538
“Indeed, inhibition of NFκB allowed cells to escape p53-mediated senescence and reduced oxidative stress in rodents [175, 177].”
Chung, H. Y., Kim, D. H., Lee, E. K., Chung, K. W., Chung, S., Lee, B., Seo, A. Y., Chung, J. H., Jung, Y. S., Im, E., et al. (2019) · Aging and disease · doi:10.14336/ad.2018.0324 · Cited by 491
“In addition, chronic activation of NF-κB has been detected in tissues including the skin, kidney, cardiac muscle, and brain (cerebellum and hypothalamus) [7,18-21].”
BackgroundInflammatory networks underlying colorectal cancer
Lasry, A., Zinger, A., & Ben-Neriah, Y. (2016) · Nature Immunology · doi:10.1038/ni.3384 · Cited by 489
Vitamin D Deficiency: Effects on Oxidative Stress, Epigenetics, Gene Regulation, and Aging
Wimalawansa, S. J. (2019) · Biology · doi:10.3390/biology8020030 · Cited by 437
“People with chronic non-communicable diseases, such as cardiovascular disease, type 2 diabetes, autoimmune diseases, arthritis, and osteoporosis are reported to have chronically elevated NF-κB [36].”
BackgroundInfluentialOsteoporosis and periodontal diseases – An update on their association and mechanistic links
Yu, B., & Wang, C. (2022) · Periodontology 2000 · doi:10.1111/prd.12422 · Cited by 407
Senescence atlas reveals an aged-like inflamed niche that blunts muscle regeneration
Moiseeva, V., Cisneros, A., Sica, V., Deryagin, O., Lai, Y., Jung, S., Andrés, E., An, J., Segalés, J., Ortet, L., et al. (2023) · Nature · doi:10.1038/s41586-022-05535-x · Cited by 423
Senescence-associated inflammatory responses: aging and cancer perspectives
Lasry, A., & Ben-Neriah, Y. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.009 · Cited by 408
Ageing and the telomere connection: An intimate relationship with inflammation
Zhang, J., Rane, G., Dai, X., Shanmugam, M. K., Arfuso, F., Samy, R. P., Lai, M. K. P., Kappei, D., Kumar, A. P., & Sethi, G. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2015.11.006 · Cited by 386
“Inhibition of NF-κB, by either genetic and pharmacological inhibitors or conditional expression of an NF-κB inhibitor in the tissues, prevents ageing associated features in a mouse model of ageing (Adler et al., 2007; Ortega- Molina et al., 2012; Tilstra et al., 2012).”
BackgroundMolecular mechanisms of biological aging in intervertebral discs
Vo, N. V., Hartman, R. A., Patil, P. R., Risbud, M. V., Kletsas, D., Iatridis, J. C., Hoyland, J. A., Le Maitre, C. L., Sowa, G. A., & Kang, J. D. (2016) · Journal of Orthopaedic Research · doi:10.1002/jor.23195 · Cited by 378
Self-citationFormation and repair of oxidatively generated damage in cellular DNA
Cadet, J., Davies, K. J. A., Medeiros, M. H., Di Mascio, P., & Wagner, J. R. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.049 · Cited by 351
“Other studies have involved Ercc-/Δ mice in which mutations led to a reduced expression of XPF-ERCC1 that affects NER efficiency and presumably leads to accumulation of both cdA and cdG with age [337,338].”
BackgroundArai, Y., Martin-Ruiz, C. M., Takayama, M., Abe, Y., Takebayashi, T., Koyasu, S., Suematsu, M., Hirose, N., & von Zglinicki, T. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.07.029 · Cited by 333
“In mice, as in humans, enhanced systemic inflammation is associated with accelerated ageing and increased mortality risk (Osorio et al., 2012; Kawahara et al., 2009; Tilstra et al., 2012; Caballero et al., 2009).”
BackgroundTissue specificity of senescent cell accumulation during physiologic and accelerated aging of mice
Yousefzadeh, M. J., Zhao, J., Bukata, C., Wade, E. A., McGowan, S. J., Angelini, L. A., Bank, M. P., Gurkar, A. U., McGuckian, C. A., Calubag, M. F., et al. (2020) · Aging Cell · doi:10.1111/acel.13094 · Cited by 331
“Previously, we demonstrated that NF-κB is activated in tissues from Ercc1−/∆ mice and that inhibition of NF-κB, through genetic depletion of the p65 subunit, delayed the onset of cellular senescence and aging in Ercc1−/∆ animals (Tilstra et al., 2012).”
BackgroundSelf-citationChronic Kidney Disease: A Clinical Model of Premature Aging
Stenvinkel, P., & Larsson, T. E. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.11.051 · Cited by 296
Cellular Senescence in the Kidney
Docherty, M.-H., O’Sullivan, E. D., Bonventre, J. V., & Ferenbach, D. A. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018121251 · Cited by 291
Cuollo, L., Antonangeli, F., Santoni, A., & Soriani, A. (2020) · Biology · doi:10.3390/biology9120485 · Cited by 291
Lagoumtzi, S. M., & Chondrogianni, N. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.003 · Cited by 279
Osorio, F. G., Bárcena, C., Soria-Valles, C., Ramsay, A. J., de Carlos, F., Cobo, J., Fueyo, A., Freije, J. M. P., & López-Otín, C. (2012) · Genes & Development · doi:10.1101/gad.197954.112 · Cited by 276
“…the specific contribution of NF-kB activation to the progeroid phenotype shown by Zmpste24-deficient 2314 GENES & DEVELOPMENT mice, we used a previously described method of NF-kB genetic reduction (Kawahara et al. 2009; Tilstra et al. 2012) based on the use of RelA-haploinsufficient mice (RelA+/ ).”
BackgroundMethodNuclear genomic instability and aging
Niedernhofer, L. J., Gurkar, A. U., Wang, Y., Vijg, J., Hoeijmakers, J. H. J., & Robbins, P. D. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012239 · Cited by 275
Self-citationCho, S.-H., Chen, J. A., Sayed, F., Ward, M. E., Gao, F., Nguyen, T. A., Krabbe, G., Sohn, P. D., Lo, I., Minami, S., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2939-14.2015 · Cited by 275
“SIRT1 could also protect against cellular senescence by inactivating NF- B (Rovillain et al., 2011; Tilstra et al., 2012) or deacetylating the FOXO3 transcription factor (Yao et al., 2012).”
BackgroundA Senescence-Centric View of Aging: Implications for Longevity and Disease
Borghesan, M., Hoogaars, W. M. H., Varela-Eirin, M., Talma, N., & Demaria, M. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.07.002 · Cited by 267
Oxidatively induced DNA damage and its repair in cancer
Dizdaroglu, M. (2015) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2014.11.002 · Cited by 254
Aging Hallmarks: The Benefits of Physical Exercise
Rebelo-Marques, A., De Sousa Lages, A., Andrade, R., Ribeiro, C. F., Mota-Pinto, A., Carrilho, F., & Espregueira-Mendes, J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00258 · Cited by 246
“Besides, the use of genetic or pharmacological inhibitors of the NF-kB signaling was associated with the prevention of age-associated features in distinct sped-up aging mouse models (32, 244).”
MethodmiR-21 and miR-146a: The microRNAs of inflammaging and age-related diseases
Olivieri, F., Prattichizzo, F., Giuliani, A., Matacchione, G., Rippo, M. R., Sabbatinelli, J., & Bonafè, M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101374 · Cited by 219
Senotherapeutics: emerging strategy for healthy aging and age-related disease
Kim, E.-C., & Kim, J.-R. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.1.293 · Cited by 208
“A peptide inhibitor of IKK, the NF-B–activating kinase, reduced cellular senescence in vitro and in vivo, and delayed the age-related symptoms and pathologies of Ercc1−/-progeroid mice (54).”
BackgroundCellular senescence: Molecular mechanisms and pathogenicity
Wei, W., & Ji, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26956 · Cited by 210
“A study found that XFE progeroid syndrome is caused by dysfunction of DNA repair, which results in the accumulation of endogenous DNA damage (Tilstra et al., 2012).”
BackgroundInfluentialTian, Y., Li, H., Qiu, T., Dai, J., Zhang, Y., Chen, J., & Cai, H. (2019) · Aging Cell · doi:10.1111/acel.12858 · Cited by 198
“NF‐κB inhibition delays DNA damage‐induced senescence and aging in mice (Salminen et al., 2012; Tilstra et al., 2012).”
BackgroundSharples, A. P., Hughes, D. C., Deane, C. S., Saini, A., Selman, C., & Stewart, C. E. (2015) · Aging Cell · doi:10.1111/acel.12342 · Cited by 201
“The inhibition of NF-Kb delays DNA damage, cellular senescence and oxidative stress during aging (Tilstra et al., 2012).”
BackgroundTelomeres, oxidative stress and inflammatory factors: partners in cellular senescence?
Correia-Melo, C., Hewitt, G., & Passos, J. F. (2014) · Longevity & Healthspan · doi:10.1186/2046-2395-3-1 · Cited by 194
“Recent investigations using progeroid mouse models (models of premature ageing) driven by DNA damage have reported that these mice have increased activation of NF-κB driven chronic inflammation and senescence [86,87].”
BackgroundCell cycle arrest and the evolution of chronic kidney disease from acute kidney injury
Canaud, G., & Bonventre, J. V. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu230 · Cited by 199
Yu, Y., Cui, Y., Niedernhofer, L. J., & Wang, Y. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00265 · Cited by 199
Self-citationGDF15, an emerging key player in human aging
Conte, M., Giuliani, C., Chiariello, A., Iannuzzi, V., Franceschi, C., & Salvioli, S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101569 · Cited by 186
Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases
Song, P., An, J., & Zou, M.-H. (2020) · Cells · doi:10.3390/cells9030671 · Cited by 198
“extrinsic factors, including telomere (the repetitive sequences of DNA at the end of eukaryotic chromosomes) attrition [16], DNA damage [22,23], accumulated cytosolic DNA from the nucleus, mitochondrial and fragmented chromatin, oncogenes such as RAS and RAF [24], mitochondrial dysfunction [25] and reactive oxygen or…”
BackgroundSingh, A., Schurman, S. H., Bektas, A., Kaileh, M., Roy, R., Wilson, D. M., Sen, R., & Ferrucci, L. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041197 · Cited by 182
Answering the ultimate question “What is the Proximal Cause of Aging?”
Blagosklonny, M. V. (2012) · Aging · doi:10.18632/aging.100525 · Cited by 190
Senotherapeutics for healthy ageing
Niedernhofer, L. J., & Robbins, P. D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.44 · Cited by 190
Self-citationHepatic stellate cell senescence in liver fibrosis: Characteristics, mechanisms and perspectives
Zhang, M., Serna-Salas, S., Damba, T., Borghesan, M., Demaria, M., & Moshage, H. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111572 · Cited by 179
“In a mouse model of aging driven by Ercc1 deficiency and presenting as the failure to repair stochastic endogenous DNA damage, additional genetic depletion of p65 attenuates aging symptoms (Tilstra et al., 2012).”
The Signaling of Cellular Senescence in Diabetic Nephropathy
Xiong, Y., & Zhou, L. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7495629 · Cited by 185
Fibroblast senescence in the pathology of idiopathic pulmonary fibrosis
Waters, D. W., Blokland, K. E. C., Pathinayake, P. S., Burgess, J. K., Mutsaers, S. E., Prele, C. M., Schuliga, M., Grainge, C. L., & Knight, D. A. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00037.2018 · Cited by 163
Role of NF-κB in Ageing and Age-Related Diseases: Lessons from Genetically Modified Mouse Models
García-García, V. A., Alameda, J. P., Page, A., & Casanova, M. L. (2021) · Cells · doi:10.3390/cells10081906 · Cited by 161
“Numerous studies have shown an increase in NF-κB activity with ageing; i.e., human fibroblasts from aged individuals and from patients with Hutchinson-Gilford progeria syndrome exhibit over-activation of NF-κB [48,49]; DNA binding to NF-κB is increased in the skin, liver, kidney, cerebellum, heart muscle, and gastric…”
BackgroundMethodInfluentialKhan, S. Y., Awad, E. M., Oszwald, A., Mayr, M., Yin, X., Waltenberger, B., Stuppner, H., Lipovac, M., Uhrin, P., & Breuss, J. M. (2017) · Scientific Reports · doi:10.1038/srep39501 · Cited by 148
Immunosenescence: signaling pathways, diseases and therapeutic targets
Fu, Y., Wang, B., Alu, A., Hong, W., Hong, L., He, X., Shi, H., Cheng, P., & Yang, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02371-z · Cited by 187
“…of the IKK/NF-κ B pathway, achieved through the deletion of one p65 allele, or pharmacological intervention via IKK inhibitors, such as 8K-NBD, has been shown to delay the onset and mitigate the severity of aging symptoms and age-related pathologies in the nervous system of murine models 10,279 .”
InfluentialSpontaneous DNA damage to the nuclear genome promotes senescence, redox imbalance and aging
Robinson, A. R., Yousefzadeh, M. J., Rozgaja, T. A., Wang, J., Li, X., Tilstra, J. S., Feldman, C. H., Gregg, S. Q., Johnson, C. H., Skoda, E. M., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.04.007 · Cited by 155
Self-citationThe multifaceted role of the SASP in atherosclerosis: from mechanisms to therapeutic opportunities
Sun, Y., Wang, X., Liu, T., Zhu, X., & Pan, X. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00815-5 · Cited by 168
Hallmarks of progeroid syndromes: lessons from mice and reprogrammed cells
Carrero, D., Soria-Valles, C., & López-Otín, C. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.024711 · Cited by 153
“…2015), whereas genetic depletion of one allele of the p65 subunit of NF-κ B or treatment with IKK inhibitors delays the age-related symptoms and pathologies of XFEPS ( XPF-ERCC1 progeroid syndrome) mice, which harbour mutations in ERCC1 (involved in DNA excision repair) (Tilstra et al., 2012).”
Chen, Y., Luo, G., Yuan, J., Wang, Y., Yang, X., Wang, X., Li, G., Liu, Z., & Zhong, N. (2014) · Mediators of Inflammation · doi:10.1155/2014/426740 · Cited by 144
Self-citationMass spectrometry for the assessment of the occurrence and biological consequences of DNA adducts
Liu, S., & Wang, Y. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00316d · Cited by 160
Self-citationPriming of microglia in a DNA-repair deficient model of accelerated aging
Raj, D. D. A., Jaarsma, D., Holtman, I. R., Olah, M., Ferreira, F. M., Schaafsma, W., Brouwer, N., Meijer, M., de Waard, M. C., van der Pluijm, I., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.025 · Cited by 170
“A recent study showed that loss of NF-k B signaling delayed DNA damage-induced aging and senescence (Tilstra et al., 2012).”
Effects of Resveratrol and other Polyphenols on Sirt1: Relevance to Brain Function During Aging
Sarubbo, F., Esteban, S., Miralles, A., & Moranta, D. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170703113212 · Cited by 153
“Similarly, genetic and pharmacological inhibition of NF-κB signaling pathway prevents age associated characteristics in different models of accelerated aging mice [155, 156].”
BackgroundDNA damage and innate immunity: links and trade-offs
Chatzinikolaou, G., Karakasilioti, I., & Garinis, G. A. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.06.003 · Cited by 158
Self-citationDiabetes and ageing‐induced vascular inflammation
Assar, M. E., Angulo, J., & Rodríguez‐Mañas, L. (2015) · The Journal of Physiology · doi:10.1113/jp270841 · Cited by 152
“Furthermore, several recent studies have shown that antagonizing NF-κB signalling can delay the ageing phenotype, demonstrating the key role that this signalling pathway plays in the ageing process of various tissues (Tilstra et al. 2012).”
BackgroundLi, Y., & Yao, H. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13518 · Cited by 147
“This is evident from findings showing that NF-κB inhibition delays cellular senescence (Tilstra et al., 2012).”
BackgroundCurcumin and o-Vanillin Exhibit Evidence of Senolytic Activity in Human IVD Cells In Vitro
Cherif, H., Bisson, D., Jarzem, P., Weber, M., Ouellet, J., & Haglund, L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040433 · Cited by 136
“Examples of senomorphic compounds, include free radical scavengers and inhibitors of IkB kinase (IKK), nuclear factor (NFkB) [8] and the Janus kinase (JAK) pathways [9].”
BackgroundMechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease
Welch, G., & Tsai, L. (2022) · The EMBO Reports · doi:10.15252/embr.202154217 · Cited by 129
“Importantly, removal of senescent cells promotes healthy aging in mice, making senescence-associated inflammatory signaling an attractive target of therapeutic intervention for aging and age-related disease (Tilstra et al , 2012; Childs et al , 2015; Baker et al , 2016; Ogrodnik et al , 2021).”
Kang, C. (2019) · PubMed · doi:10.14348/molcells.2019.0298 · Cited by 121
Replication Stress, DNA Damage, Inflammatory Cytokines and Innate Immune Response
Ragu, S., Matos-Rodrigues, G. E., & López, B. S. (2020) · Genes · doi:10.3390/genes11040409 · Cited by 142
Genome Integrity in Aging: Human Syndromes, Mouse Models, and Therapeutic Options
Vermeij, W. P., Hoeijmakers, J. H. J., & Pothof, J. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124316 · Cited by 124
Sirtuins in neurodegenerative diseases: an update on potential mechanisms
Min, S.-W., Sohn, P. D., Cho, S.-H., Swanson, R. A., & Gan, L. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00053 · Cited by 123
“Genetic reduction of p65 subunit or pharmacological inhibition of NF-κB delayed the onset of progeroid symptoms in accelerated aging mouse model caused by a defect in DNA repair (Tilstra et al., 2012).”
BackgroundZhao, J., Zhang, L., Lu, A., Han, Y., Colangelo, D., Bukata, C., Scibetta, A., Yousefzadeh, M. J., Li, X., Gurkar, A. U., et al. (2020) · Aging · doi:10.18632/aging.102863 · Cited by 122
“improves bone architecture and reduces osteoporosis [34, 35].”
BackgroundSelf-citationNF‐κB as the mediator of metformin's effect on ageing and ageing‐related diseases
Kanigur Sultuybek, G., Soydas, T., & Yenmis, G. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13073 · Cited by 119
Yousefzadeh, M. J., Schafer, M. J., Noren Hooten, N., Atkinson, E. J., Evans, M. K., Baker, D. J., Quarles, E. K., Robbins, P. D., Ladiges, W. C., LeBrasseur, N. K., et al. (2018) · Aging Cell · doi:10.1111/acel.12706 · Cited by 114
Self-citationSystemic DNA damage responses in aging and diseases
Ribezzo, F., Shiloh, Y., & Schumacher, B. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.12.005 · Cited by 116
“Inhibition of NF-κB signalling could attenuate progeroid features in HGPS as well as in progeroid Ercc1 mutants mice, supporting the idea that inflammatory responses play a major role in the agingassociated pathologies [114,115].”
Molecular insights into the premature aging disease progeria
Vidak, S., & Foisner, R. (2016) · Histochemistry and Cell Biology · doi:10.1007/s00418-016-1411-1 · Cited by 112
“NF-κB, an important transcription factor activated as a response to damage, stress and inflammation (Ghosh and Hayden 2008) and during aging (Tilstra et al. 2012), was found to be hyperactivated in progeroid mice (Zmpste24−/− and LmnaG609G knock-in mice) (Osorio et al. 2012).”
BackgroundDirect Action of Endothelin-1 on Podocytes Promotes Diabetic Glomerulosclerosis
Lenoir, O., Milon, M., Virsolvy, A., Hénique, C., Schmitt, A., Massé, J., Kotelevtsev, Y. V., Yanagisawa, M., Webb, D. J., Richard, S., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013020195 · Cited by 114
Mouse Models to Disentangle the Hallmarks of Human Aging
Folgueras, A. R., Freitas-Rodríguez, S., Velasco, G., & López-Otín, C. (2018) · Circulation Research · doi:10.1161/circresaha.118.312204 · Cited by 113
“Accordingly, different mouse models of accelerated aging show exacerbated inflammatory condition through enhanced NF-κB signaling, whose inhibition significantly improved the progeroid phenotype and even extended mice lifespan, supporting the contribution of chronic inflammation to the aging process.(232,233) In agree…”
BackgroundFlores, R. R., Clauson, C. L., Cho, J., Lee, B.-C., McGowan, S. J., Baker, D. J., Niedernhofer, L. J., & Robbins, P. D. (2017) · Aging Cell · doi:10.1111/acel.12571 · Cited by 107
“The Ercc1 /Δ mouse has reduced expression of the DNA endonuclease ERCC1-XPF (Gregg et al., 2012; Tilstra et al., 2012), which results in accelerated aging in mice, like humans (Niedernhofer et al., 2006).”
BackgroundSelf-citationTargeting senescence as an anticancer therapy
Bousset, L., & Gil, J. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13312 · Cited by 105
CCN1 induces hepatic ductular reaction through integrin αvβ5–mediated activation of NF-κB
Kim, K.-H., Chen, C.-C., Alpini, G., & Lau, L. F. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79327 · Cited by 109
“To demonstrate further that the proliferative effects of CCN1 on cholangiocytes are mediated through NF-κ B, we have also used the NEMO-binding domain (NBD) peptide to inhibit NF-κ B activation (45).”
MethodYao, H., & Rahman, I. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00175.2012 · Cited by 114
Topical hypochlorite ameliorates NF-κB–mediated skin diseases in mice
Leung, T. H., Zhang, L. F., Wang, J., Ning, S., Knox, S. J., & Kim, S. K. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70895 · Cited by 107
“Skin aging induces the expression of RAD50, a DNA repair protein, and p16INK4A, a cell-cycle regulator (11, 12, 38).”
Self-citationLiu, Y., Hawkins, O. E., Su, Y., Vilgelm, A. E., Sobolik, T., Thu, Y., Kantrow, S., Splittgerber, R. C., Short, S., Amiri, K. I., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201378 · Cited by 99
“Another mouse model demonstrated that NF-k B inhibition by either genetic depletion or a pharmacological inhibitor attenuates DNA damage and delays DNA damage-induced senescence (Tilstra et al, 2012).”
Autophagy: Multiple Mechanisms to Protect Skin from Ultraviolet Radiation-Driven Photoaging
Wang, M., Pourzand, C., Lei, X., & Zhong, J. L. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8135985 · Cited by 111
“The NF-κB pathway is involved in accelerating the progression of aging [117], and NF-κB attenuates oxidative stress and DNA damage and delays cellular senescence [118].”
BackgroundKhan, M., Ullah, R., Rehman, S. U., Shah, S. A., Saeed, K. M., Muhammad, T., Park, H. Y., Jo, M. H., Choe, K., Rutten, B. P. F., et al. (2019) · Cells · doi:10.3390/cells8080928 · Cited by 107
Cellular senescence and tumor promotion: Is aging the key?
Loaiza, N., & Demaria, M. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.01.007 · Cited by 101
Senescence-associated secretory phenotype in a mouse model of bleomycin-induced lung injury
Aoshiba, K., Tsuji, T., Kameyama, S., Itoh, M., Semba, S., Yamaguchi, K., & Nakamura, H. (2013) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2013.04.001 · Cited by 100
Ali, A., Shah, S. A., Zaman, N., Uddin, M. N., Khan, W., Ali, A., Riaz, M. S., & Kamil, A. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104893 · Cited by 106
Alzheimer’s Disease and Inflammaging
Kosyreva, A., Sentyabreva, A., Tsvetkov, I., & Makarova, O. (2022) · Brain Sciences · doi:10.3390/brainsci12091237 · Cited by 98
“determines its prolonged effect on the expression of target genes [18].”
BackgroundThe Menin–Bach2 axis is critical for regulating CD4 T-cell senescence and cytokine homeostasis
Kuwahara, M., Suzuki, J., Tofukuji, S., Yamada, T., Kanoh, M., Matsumoto, A., Maruyama, S., Kometani, K., Kurosaki, T., Ohara, O., et al. (2014) · Nature Communications · doi:10.1038/ncomms4555 · Cited by 98
Loss of Nfkb1 leads to early onset aging
Bernal, G. M., Wahlstrom, J. S., Crawley, C. D., Cahill, K. E., Pytel, P., Liang, H., Kang, S., Weichselbaum, R. R., & Yamini, B. (2014) · Aging · doi:10.18632/aging.100702 · Cited by 97
“While these findings indicate that loss of NF-κB accelerates aging, previous studies note the reverse, that inhibition of NF-κB actually delays certain age-related findings [8, 29].”
BackgroundNF-κB activation impairs somatic cell reprogramming in ageing
Soria-Valles, C., Osorio, F. G., Gutiérrez-Fernández, A., De Los Angeles, A., Bueno, C., Menéndez, P., Martín-Subero, J. I., Daley, G. Q., Freije, J. M. P., & López-Otín, C. (2015) · Nature Cell Biology · doi:10.1038/ncb3207 · Cited by 95
RetractedA small molecule inhibitor of PAI-1 protects against doxorubicin-induced cellular senescence
Ghosh, A. K., Rai, R., Park, K. E., Eren, M., Miyata, T., Wilsbacher, L. D., & Vaughan, D. E. (2016) · Oncotarget · doi:10.18632/oncotarget.12494 · Cited by 94
“NFκB is one of the critical nuclear factors upregulated by enhanced oxidative stress and plays a key role in senescence [23].”
BackgroundAndrade, B., Jara‐Gutiérrez, C., Paz-Araos, M., Vázquez, M. C., Díaz, P., & Murgas, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315182 · Cited by 101
Sarubbo, F., Ramis, M. R., Kienzer, C., Aparicio, S., Esteban, S., Miralles, A., & Moranta, D. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9759-0 · Cited by 98
“The pharmacological inhibition of NF-κB has been shown to prevent the occurrence of different types of inflammation in mouse models of premature aging (Gillum et al. 2011; Osorio et al. 2012; Tilstra et al. 2012; Yao et al. 2012; Zhang et al. 2010).”
BackgroundResveratrol: Why Is It a Promising Therapy for Chronic Kidney Disease Patients?
Saldanha, J. F., Leal, V. D. O., Stenvinkel, P., Carraro-Eduardo, J. C., & Mafra, D. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/963217 · Cited by 93
“Inflammation and oxidative stress, which are common features in patients with chronic kidney disease (CKD), are interrelated and associated with cardiovascular disease and the progression of CKD itself.”
BackgroundEpigenetic Mechanisms Impacting Aging: A Focus on Histone Levels and Telomeres
Song, S., & Johnson, F. B. (2018) · Genes · doi:10.3390/genes9040201 · Cited by 101
“Inhibition of NF-κB reduces oxidative stress, oxidative DNA damage and senescence, both in cultured cells and mice [183].”
BackgroundHsp90 inhibitors as senolytic drugs to extend healthy aging
Fuhrmann-Stroissnigg, H., Niedernhofer, L. J., & Robbins, P. D. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1475828 · Cited by 92
Self-citation
Metadata
- Authors
- Tilstra, J. S., Robinson, A. R., Wang, J., Gregg, S. Q., Clauson, C. L., Reay, D. P., Nasto, L. A., St Croix, C. M., Usas, A., Vo, N., Huard, J., Clemens, P. R., Stolz, D. B., Guttridge, D. C., Watkins, S. C., Garinis, G. A., Wang, Y., Niedernhofer, L. J., & Robbins, P. D.
- Affiliations
- University of Pittsburgh (US)
- University of California, Riverside (US)
- Foundation for Research and Technology Hellas (GR)
- Scripps Research Institute (US)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2012-07-02
- Volume
- 122
- Issue
- 7
- Pages
- 2601-2612
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3386805
- OpenAlex
- W2116435487
- Cited by
- 462
- References
- 87
- Citations by year
- 2026: 30 · 2025: 30 · 2024: 33 · 2023: 34 · 2022: 43 · 2021: 37 · 2020: 39 · 2019: 26 · 2018: 37 · 2017: 23 · 2016: 30 · 2015: 36 · 2014: 26 · 2013: 26 · 2012: 11
- FWCI
- 10.29
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- D-Scholarship@Pitt (University of Pittsburgh) (acceptedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Funders
- National Institute on Aging (R21AG033907, AG032816, AG 024827, R21AG033046, AG033907, AG-NS-0303-05, F30AG032816, AG033046, P30AG024827)
- National Cancer Institute (CA101864, CA103730, R01CA101864, P20CA103730, P30CA047904)
- National Institute of Environmental Health Sciences (R01ES019873, ES 016114, R01ES016114, ES019873)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR051456, R01AR051456)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- NF-κB, DNA damage, cellular senescence, aging, accelerated aging, DNA repair, IKK inhibition, p65 subunit, oxidative DNA damage, stress response, degenerative diseases
- MeSH terms
- Aging, Animals, Cell Nucleus, Cells, Cultured, DNA Damage, DNA-Binding Proteins, Endonucleases, Gene Expression Regulation, Mice, Transgenic, Peptides, Phosphorylation, Progeria, Protein Binding, Signal Transduction, Transcriptional Activation, Cellular Senescence, Oxidative Stress, Cyclin-Dependent Kinase Inhibitor p16, Hepatocytes, Mice, I-kappa B Kinase, Transcription Factor RelA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.